Cell Therapy News/Articles, page-17950

You invoke Matt Klinker - I'm used to you reg.

If you have any evidence at all that Matt Klinker has personally said anywhere that he has changed his mind about Mesoblast in particular - then that would be a fantastic pump for MSB.

I am saying on my own authority that Matt Klinker understands what was wrong with the BLA the first time. Because I read what he said and I read his papers.

I am saying on my own authority I would have expected Matt Klinker and his group including Steve Bauer to have rejected the last BLA - because they would see the same holes in the data or similar one's - and probably more - as I saw. They weren't hiding the errors were in the open.

If Silviu had any evidence of that (Matt Linker specifically changing his mind on potency assays specifically to do with MSB) - and could - without breaching any other legal or moral duties put that and the reason for Matt Klinker's change of mind - specifically - into the public domain - this stock might go to the moon - as the dimwits are inclined to post - that news - would have than much impact.

But you don't do you. Silviu neither.